Delivery of AAV-IGF-1 to the CNS Extends Survival in ALS Mice Through Modification of Aberrant Glial Cell Activity
Open Access
- 1 June 2008
- journal article
- Published by Elsevier BV in Molecular Therapy
- Vol. 16 (6), 1056-1064
- https://doi.org/10.1038/mt.2008.60
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Intraparenchymal spinal cord delivery of adeno-associated virus IGF-1 is protective in the SOD1G93A model of ALSBrain Research, 2007
- Mutant SOD1G93A microglia are more neurotoxic relative to wild‐type microgliaJournal of Neurochemistry, 2007
- Non–cell autonomous effect of glia on motor neurons in an embryonic stem cell–based ALS modelNature Neuroscience, 2007
- Correction of humoral derangements from mutant superoxide dismutase 1 spinal cordAnnals of Neurology, 2006
- Gene transfer demonstrates that muscle is not a primary target for non-cell-autonomous toxicity in familial amyotrophic lateral sclerosisProceedings of the National Academy of Sciences, 2006
- Efficient Neuronal Gene Transfer with AAV8 Leads to Neurotoxic Levels of Tau or Green Fluorescent ProteinsMolecular Therapy, 2006
- Directed Differentiation of Embryonic Stem Cells into Motor NeuronsCell, 2002
- Experimental Models of Amyotrophic Lateral SclerosisNeurobiology of Disease, 1999
- Projections from the central cervical nucleus to the cerebellar nuclei in the rat, studied by anterograde axonal tracingJournal of Comparative Neurology, 1995
- Projections from the spinal cord to the cerebellar nuclei in the rabbit and ratExperimental Neurology, 1973